लोड हो रहा है...
Biopsy Misidentification Identified by DNA Profiling in a Large Multicenter Trial
PURPOSE: The Reduction by Dutasteride of Prostate Cancer Events (REDUCE) prostate cancer risk reduction study randomly assigned 8,231 men to dutasteride or placebo for 4 years. Protocol-mandated biopsies were obtained after 2 and 4 years. After the discovery of three cases of biopsy sample misidenti...
में बचाया:
मुख्य लेखकों: | , , , , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
American Society of Clinical Oncology
2011
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107764/ https://ncbi.nlm.nih.gov/pubmed/21444877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.1646 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|